Overview Financials News + Filings Key Docs Charts Ownership Insiders |
IMAX CORP (IMAX)
|
Add to portfolio |
|
|
Price: |
$18.92
| | Metrics |
OS: |
54.0
|
M
| |
|
|
Market cap: |
$1.02
|
B
| |
|
|
Net cash:
|
$97.4
|
M
| |
$1.80
|
per share
|
EV:
|
$924
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
|
| |
|
|
EBIT
|
|
| |
|
|
EPS |
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-05-22 | Dec-31-21 | Dec-05-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
Revenues | 300.8 | 300.8 | 254.9 | 254.9 | 137.0 | 395.7 | 374.4 | 380.8 |
Revenue growth | 18.0% | 18.0% | 86.0% | | -65.4% | 5.7% | -1.7% | 0.9% |
Cost of goods sold | 144.5 | 144.5 | 120.5 | 120.5 | 115.5 | 181.5 | 166.5 | 195.5 |
Gross profit | 156.4 | 156.4 | 134.4 | 134.4 | 21.5 | 214.2 | 207.9 | 185.2 |
Gross margin | 52.0% | 52.0% | 52.7% | 52.7% | 15.7% | 54.1% | 55.5% | 48.7% |
Selling, general and administrative | 56.7 | 138.0 | 56.1 | 117.3 | 52.7 | 123.5 | 117.5 | 109.9 |
Research and development | | 5.3 | | 6.9 | | 5.2 | 13.7 | 20.9 |
EBITA | 99.7 | 4.5 | 78.3 | 15.9 | -31.2 | 83.1 | 61.4 | 49.9 |
EBITA margin | 33.1% | 1.5% | 30.7% | 6.2% | -22.7% | 21.0% | 16.4% | 13.1% |
Amortization of intangibles | | 4.8 | | 4.9 | | 5.0 | 4.1 | 3.0 |
EBIT | 99.7 | -0.4 | 78.3 | 11.0 | -31.2 | 78.1 | 57.2 | 46.9 |
EBIT margin | 33.1% | -0.1% | 30.7% | 4.3% | -22.7% | 19.7% | 15.3% | 12.3% |
Pre-tax income | -9.8 | -9.8 | 11.0 | 11.0 | -129.1 | 75.3 | 43.6 | 30.0 |
Income taxes | 10.1 | 10.1 | 20.6 | 20.6 | 26.5 | 16.8 | 9.5 | 16.8 |
Tax rate | | | 187.2% | 187.2% | | 22.3% | 21.8% | 55.9% |
Net income | -19.9 | 0.0 | -9.6 | 0.0 | -157.5 | 58.6 | 33.6 | 12.5 |
Net margin | -6.6% | 0.0% | -3.8% | 0.0% | -115.0% | 14.8% | 9.0% | 3.3% |
|
Diluted EPS | ($0.35) | ($0.40) | ($0.16) | ($0.38) | ($2.66) | $0.95 | $0.53 | $0.19 |
Shares outstanding (diluted) | 56.7 | 0.1 | 59.1 | 0.1 | 59.2 | 61.5 | 63.2 | 65.5 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|